Andres Ruiz Briseno serves as the Senior Vice President, Head of Finance and Investor Relations at IDEAYA Biosciences Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics. In his role, Andres is responsible for overseeing the company's financial strategy, planning, and reporting, as well as managing relationships with investors and stakeholders. His leadership has been instrumental in guiding IDEAYA through its growth and development, ensuring the company's financial health and transparency with the investment community. Before joining IDEAYA Biosciences, Andres accumulated extensive experience in the biotechnology and pharmaceutical industries. He previously held positions at leading companies such as Genentech and Amgen, where he honed his skills in financial management, strategic planning, and investor relations. Andres's background in these roles equipped him with a deep understanding of the unique financial challenges and opportunities within the life sciences sector. His expertise has been vital in helping IDEAYA navigate the complex landscape of drug development and commercialization. Andres's achievements at IDEAYA include successfully leading the company through multiple financing rounds, which have provided the necessary capital to advance the company's pipeline of innovative cancer therapies. Under his guidance, IDEAYA has strengthened its position in the competitive oncology market, attracting significant investment and partnerships. Andres's strategic vision and commitment to excellence continue to drive IDEAYA's financial strategy, supporting the company's mission to bring transformative treatments to patients with cancer.